HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.

AbstractOBJECTIVE:
The relationship of cardiovascular disease (CVD) with plasma cholesteryl ester transfer protein (CETP) levels is controversial. We determined whether plasma cholesteryl ester transfer (CET), reflecting CETP-mediated transfer of cholesteryl esters from endogenous HDL towards apolipoprotein B-lipoproteins, predicts incident CVD.
METHODS:
A prospective nested case-control study was carried out in 114 men who developed CVD and 105 controls. Participants did not use lipid lowering drugs at baseline. Plasma CET was assayed using an isotope method.
RESULTS:
Plasma CET was 19% higher (P=0.030), whereas CETP mass was unaltered (P=0.30) in cases vs. controls. Plasma CET predicted CVD (age-adjusted hazard ratio (HR): 1.20 (95% CI 1.02-1.46, P=0.028), but incident CVD was unrelated to CETP mass (HR: 0.88 (95% CI 0.73-1.07), P=0.20). Plasma CET still predicted CVD after additional adjustment for total cholesterol/HDL cholesterol, triglycerides and non-lipid risk markers (HR: 1.22 (95% CI 1.02-1.46, P=0.031).
CONCLUSION:
Plasma CET rather than CETP mass may be a determinant of cardiovascular risk.
AuthorsPaul J W H Kappelle, Frank Perton, Hans L Hillege, Geesje M Dallinga-Thie, Robin P F Dullaart
JournalAtherosclerosis (Atherosclerosis) Vol. 217 Issue 1 Pg. 249-52 (Jul 2011) ISSN: 1879-1484 [Electronic] Ireland
PMID21524747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Apolipoproteins B
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Cholesterol Esters
  • Lipoproteins, HDL
Topics
  • Aged
  • Apolipoproteins B (metabolism)
  • Cardiovascular Diseases (blood, diagnosis)
  • Case-Control Studies
  • Cholesterol Ester Transfer Proteins (blood)
  • Cholesterol Esters (blood)
  • Gene Expression Regulation
  • Humans
  • Lipoproteins, HDL (metabolism)
  • Male
  • Middle Aged
  • Prospective Studies
  • Regression Analysis
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: